2021 NOSCM | Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

2021 NOSCM | Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Mohamed Kharfan-Dabaja, MD

Disclosure

Mohamed Kharfan-Dabaja, MD discloses no such relationships exist

Accreditation

NA